Impact of Myocardial Blush Grade on In-Hospital Outcome after Primary Percutaneous Coronary Intervention

M M Arefin1, A Rahman, S K Kundu

  • 1Dr Md Minhaj Arefin, Assistant Registrar, Department of Cardiology, National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh;

Insights

Assessing myocardial blush grade (MBG) after primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI) is crucial. Low MBG indicates incomplete reperfusion and predicts worse in-hospital outcomes, even with TIMI 3 flow.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Myocardial Infarction Research

Background:

  • Primary percutaneous coronary intervention (PPCI) is the standard reperfusion therapy for ST-elevation myocardial infarction (STEMI).
  • Myocardial tissue-level perfusion, assessed by Myocardial Blush Grade (MBG), can be suboptimal despite successful TIMI 3 flow post-PPCI.
  • Suboptimal MBG is linked to adverse clinical outcomes in STEMI patients.

Purpose of the Study:

  • To investigate the association between Myocardial Blush Grade (MBG) and in-hospital outcomes in STEMI patients undergoing primary PCI.
  • To determine if MBG is an independent predictor of adverse outcomes after PPCI.

Main Methods:

  • A prospective observational study included 74 STEMI patients who achieved TIMI 3 flow after PPCI.
  • Patients were divided into low MBG (grade 0-1) and high MBG (grade II-III) groups.
  • Clinical characteristics, procedural data, and in-hospital complications were analyzed.

Main Results:

  • The low MBG group had significantly higher rates of smoking, diabetes mellitus, multi-vessel involvement, and anterior MI.
  • Left ventricular ejection fraction (LVEF) was significantly lower in the low MBG group.
  • Acute heart failure, total adverse in-hospital outcomes, and mortality were significantly higher in the low MBG group.

Conclusions:

  • Low Myocardial Blush Grade (MBG) is an independent predictor of adverse in-hospital outcomes following primary PCI in STEMI patients.
  • Assessing MBG alongside TIMI 3 flow is essential for evaluating complete reperfusion and predicting patient outcomes.
  • These findings highlight the importance of optimizing myocardial perfusion beyond epicardial flow restoration.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
46
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
108
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
76
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
85
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
233